Global Consortium, Inc. Schedules Investor
Conference Call for March
22,
2019
Appoints
SmallCapVoice.com, Inc.
as
Investor Relations Contact for the
Company
COCONUT CREEK, FL -- March
6, 2019 -- InvestorsHub NewsWire -- Global Consortium,
Inc., (OTC: GCGX)
(the
"Company"),
builder
of America's first
Cannabis Mall, which when completed will house Manufacturing,
Distribution, Delivery, Retail, Testing, and Cultivation all under
one 64,000 square foot building, today
announced that they
have
scheduled an
investor conference call for 4:30 PM eastern standard time
on Friday,
March
22,
2019.
Global
Consortium CEO Matt Dwyer
and other members of
the GCGX management team will provide
updates on recent
developments and discuss the
goals for the Company in 2019.
In addition,
interested parties have the opportunity to submit questions
concerning the Company prior to the call to Stuart Smith at
SmallCapVoice.Com, Inc. via email: ssmith@smallcapvoice.com by
12:00 PM eastern standard time on Monday
March
18th,
2019.
Mr. Smith will compile a list of questions and submit them to the
Company prior to the conference call. Which questions will be
addressed will be based on the relevance to the shareholder base,
and the question's appropriateness in light of public
disclosure
rules.
To access the
call:
Dial-In Number:
1-857-232-0157
Access Code:
422095
For those unable
to participate in the conference call at that
time, a replay will
be available at https://www.smallcapvoice.com/gcgx/
shortly
after the call has concluded.
In other
news, Global
Consortium, Inc. has appointed
SmallCapVoice.com, Inc. as the investor relations contact for the
Company going forward. SmallCapVoice will handle the investor
inquiries, compile questions for management for upcoming
appearances and interviews, and provide a host of other corporate
communications duties for the Company.
About
Global Consortium, Inc.
Global
Consortium, Inc., is building America's first Cannabis Mall, which
when completed will house Manufacturing, Distribution, Delivery,
Retail, Testing, and Cultivation all under one 64,000 square foot
building. The Mall will house the largest Manufacturing facility of
THC and CBD Distillate and Edibles believed to be operational in
the United States.
Global
Consortium, Inc., in compliance with SEC regulations, may in the
future use social media outlets like Facebook or Twitter and its
own website to announce key information in compliance with Reg.
FD.
Forward-Looking
Statements
This news
release contains "forward-looking statements" as that term is
defined in Section 27(a) of the United States Securities Act of
1933, as amended and Section 21(e) of the Securities Exchange Act
of 1934, as amended. Statements in this press release which are not
purely historical are forward-looking statements and include any
statements regarding beliefs, plans, expectations or intentions
regarding the future. Such forward-looking statements include,
among other things, estimates
of services and equipment markets, the release of corporate apps,
growth of the platform, target markets, product releases, product
demand and, business strategy. Actual
results could differ from those projected in any forward-looking
statements due to numerous factors. Such factors include, among
others, the inherent uncertainties associated with new projects and
development stage companies. These forward-looking statements are
made as of the date of this news release, and we assume no
obligation to update the forward-looking statements or to update
the reasons why actual results could differ from those projected in
the forward-looking statements. Although we believe that any
beliefs, plans, expectations and intentions contained in this press
release are reasonable, there can be no assurance that any such
beliefs, plans, expectations or intentions will prove to be
accurate. Investors should consult all of the information set forth
herein and should also consider that any investment in securities
is at risk.
Details of the
Company's business, finances, appointments, and agreements can be
found as part of the Company's continuous public disclosure
on otcmarkets.com.
For additional information
about this release please contact:
Investor
Relations:
www.SmallCapVoice.com
Stuart Smith
512-267-2430
investor@gcgx.com